Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Frontiers in Neurology
|
November 4, 2024
Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
Barry J Byrne, Giancarlo Parenti, Benedikt Schoser, et al.
Nature Communications
|
October 18, 2018
Cancer exosomes induce tumor innervation
Marianna Madeo, Paul L Colbert, Daniel W Vermeer, et al.
Frontiers in Neurology
|
January 20, 2025
Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
Barry J Byrne, Giancarlo Parenti, Benedikt Schoser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 24, 2019
Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease
Jacob T Cain, Shibi Likhite, Katherine A White, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease
Matthew P Stratton, Jessica L Centa, Vicki J Swier, et al.
Pain
|
June 28, 2019
Assessment of nociception and related quality-of-life measures in a porcine model of neurofibromatosis type 1
Rajesh Khanna, Aubin Moutal, Katherine A White, et al.
Nucleic Acids Research
|
November 5, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease
Matthew P Stratton, Jessica L Centa, Vicki J Swier, et al.
Communications Biology
|
February 6, 2021
A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface
Cynthia Tang, Jimin Han, Sonal Dalvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 23, 2020
RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors
Jordan L Kohlmeyer, Courtney A Kaemmer, Casey Pulliam, et al.
Disease Models & Mechanisms
|
September 20, 2022
Promoting validation and cross-phylogenetic integration in model organism research
Keith C Cheng, Rebecca D Burdine, Mary E Dickinson, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Frontiers in Neurology
|
November 4, 2024
Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
Barry J Byrne, Giancarlo Parenti, Benedikt Schoser, et al.
Nature Communications
|
October 18, 2018
Cancer exosomes induce tumor innervation
Marianna Madeo, Paul L Colbert, Daniel W Vermeer, et al.
Frontiers in Neurology
|
January 20, 2025
Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
Barry J Byrne, Giancarlo Parenti, Benedikt Schoser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 24, 2019
Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease
Jacob T Cain, Shibi Likhite, Katherine A White, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease
Matthew P Stratton, Jessica L Centa, Vicki J Swier, et al.
Pain
|
June 28, 2019
Assessment of nociception and related quality-of-life measures in a porcine model of neurofibromatosis type 1
Rajesh Khanna, Aubin Moutal, Katherine A White, et al.
Nucleic Acids Research
|
November 5, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease
Matthew P Stratton, Jessica L Centa, Vicki J Swier, et al.
Communications Biology
|
February 6, 2021
A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface
Cynthia Tang, Jimin Han, Sonal Dalvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 23, 2020
RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors
Jordan L Kohlmeyer, Courtney A Kaemmer, Casey Pulliam, et al.
Disease Models & Mechanisms
|
September 20, 2022
Promoting validation and cross-phylogenetic integration in model organism research
Keith C Cheng, Rebecca D Burdine, Mary E Dickinson, et al.
Page
of 9